ALISO VIEJO, Calif., July 25, 2017 -- NVISION Eye Centers, a national leader in providing the finest suite of ophthalmology services for patients, is pleased to welcome Scott Asher to its leadership team as Vice President of Corporate Development.
“I’m excited to welcome Scott to the NVISION family and leadership team," said Tom Tooma, founder of NVISION. “His proven track record of driving strategic corporate initiatives will be key as we continue to expand our organization.”
Prior to joining NVISION’s leadership team, Scott served as Vice President of Corporate Development at Vantage Oncology/McKesson, where he was responsible for the development of relationships and strategic transactions with physicians, healthcare systems, payers and other strategic partners in the oncology sector.
He also served as Director of Corporate Development at DaVita Inc., one of the nation’s largest providers of dialysis and related services. His responsibilities included leading valuation, structuring, diligence, negotiation and execution of acquisitions, divestitures and joint ventures.
“NVISION Eye Centers is recognized as an exceptional leader in ophthalmology, and I’m excited to join such an innovative and dedicated team,” says Scott Asher. “With my background in finance and business strategy, paired with my experience in the healthcare industry, I look forward to building and expanding our network of partners to help even more patients see clearly.”
Before joining DaVita, Scott worked at Clear Capital Advisors focusing on middle market M&A advisory and capital raising, at Bear Stearns in both New York and Los Angeles in the Leveraged Finance/Financial Sponsors Group, and also as part of the M&A team. Scott began his professional career at Prudential Capital Group, a middle-market private placement lender participating in and originating senior debt, subordinated debt and mezzanine financings.
Scott is a graduate of The State University of New York at Geneseo and earned his MBA from the University of Rochester, NY.
ABOUT NVISION EYE CENTERS: NVISION Eye Centers is the premier provider of LASIK and cataract surgery in the U.S., with centers in California, Arizona, Nevada, Oregon, and Toronto, Canada. An innovative leader in ophthalmology, NVISION is dedicated to providing the best patient experience through the use of the latest technology and treatment by the most talented and experienced surgeons in the industry. NVISION was founded in 2010 by Tom Tooma, M.D., one of the earliest pioneers of LASIK who has performed more than 120,000 procedures throughout his esteemed career. With more than 2,000 eye doctors referring their patients and trusting their own eyes to NVISION surgeons, NVISION Eye Centers is the Eye Doctors' #1 Choice®.
For more information, visit www.NVISIONCenters.com or call (877) 455-9942.


SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
Instagram Outage Disrupts Thousands of U.S. Users
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Washington Post Publisher Will Lewis Steps Down After Layoffs
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge 



